The authors retrospectively analyzed hepatitis A virus (HAV) seroprevalence in travellers who had been born and lived at least 1 year in a developing country, wanted to travel to a hepatitis A endemic area, and consulted at the vaccination centre of the Institut Pasteur of Paris between September 1, 2008 and February 28, 2010. HAV seroprevalence was 82.4 % for a population of 646 immigrants for whom data were available
This study establishes whether the immunisation with hexavalent vaccines increased the short term risk of sudden unexpected deaths (SUD) in infants in Italy, following the signal of an association between vaccination in the second year of life with a hexavalent vaccine and SUD in the two days following vaccination reported in Germany in 2003.
ECDC Director Marc Sprenger and WHO/Europe Regional Director Zsuzsanna Jakab have signed an Administrative Agreement between ECDC and WHO/Europe during the 8th Senior Officials Meeting of the European Commission (EC) and World Health Organisation (WHO), held in Brussels on 24-25 March 2011.
Vaccination helps to prevent diseases and, above all, saves lives. This was the message at an expert meeting on childhood immunisation organised by the Hungarian Presidency. ECDC Director Marc Sprenger stressed the importance of successful vaccination programmes across Europe and future challenges.